[{"question": "Drugs which is not metabolized by acetylation ?", "correct_answer": "Metoclopramide", "correct_idx": 1, "options": ["A)Dapsone", "B)Metoclopramide", "C)Procainamide", "D)INH"], "prompt": "Drugs which is not metabolized by acetylation ?A)Dapsone\nB)Metoclopramide\nC)Procainamide\nD)INH", "subject_name": "Pharmacology", "output0": "Dapsone is not metabolized by acetylation. It is metabolized by a different pathway, called hydrolysis.\n\n", "output1": "Metoclopramide is not metabolized by acetylation because it is a substrate for the enzyme catechol-O-methyltransferase (COMT). COMT is responsible for the metabolism of many drugs, including metoclopramide, by O-methylation.\n\n", "output2": "Procainamide is not metabolized by acetylation, it is metabolized by oxidation.\n\n", "output3": "INH (Isoniazid) is not metabolized by acetylation. It is metabolized by the enzyme catalase. The other options, Dapsone, Metoclopramide, and Procainamide, are all metabolized by acetylation.\n\n"}, {"question": "The reliability coefficient of a test increases when:", "correct_answer": "Increase the variability of the sample.", "correct_idx": 0, "options": ["A)Increase the variability of the sample.", "B)Decrease the number of items.", "C)Increase dimensionality", "D)Decreases its predictive validity."], "prompt": "The reliability coefficient of a test increases when:A)Increase the variability of the sample.\nB)Decrease the number of items.\nC)Increase dimensionality\nD)Decreases its predictive validity.", "subject_name": "psychology", "output0": "The reliability coefficient of a test increases when the variability of the sample increases. This is because a larger sample size with more variability provides a more accurate representation of the population, which in turn increases the reliability of the test.\n\n", "output1": "Decreasing the number of items in a test can increase its reliability coefficient. This is because a shorter test with fewer items is less likely to have random errors, which can increase the reliability of the test.\n\n", "output2": "Increasing the dimensionality of a test can increase the reliability coefficient because it allows for more precise measurements of the construct being measured. This is because adding more items or dimensions to a test can provide more information about the construct, which can help to reduce the error variance and increase the reliability of the test.\n\n", "output3": "When the reliability coefficient of a test increases, it means that the test is more consistent and reliable. This can happen when the test is more focused on a specific aspect of the construct being measured, which can increase its predictive validity. However, if the test is too narrow in focus, it may not be able to capture the full range of the construct, which can decrease its predictive validity and increase the variability of the sample.\n\n"}, {"question": "10 patients because of a drinking confusion, severe vomiting were sent to the emergency room. Arterial blood and the blood biochemical examination as follows: pH: 7.40, PaCO2: 40 mmHg, HCO3-: 24 mEq / L, Glucose: 120 mg / dL, BUN: 10 mg / dL, Cr: 0.7 mg / dL, Na: 134 mEq / L\n\u00a06 mEq / L, Cl: 80 mEq / L, Acetone: 3+. Then the following statements is true?", "correct_answer": "Patients with metabolic acidosis with metabolic alkalosis", "correct_idx": 1, "options": ["A)Patients with normal blood pH without metabolic acid-base disorders", "B)Patients with metabolic acidosis with metabolic alkalosis", "C)Patients with metabolic acidosis with respiratory alkalosis", "D)Patients with metabolic alkalosis with respiratory acidosis"], "prompt": "10 patients because of a drinking confusion, severe vomiting were sent to the emergency room. Arterial blood and the blood biochemical examination as follows: pH: 7.40, PaCO2: 40 mmHg, HCO3-: 24 mEq / L, Glucose: 120 mg / dL, BUN: 10 mg / dL, Cr: 0.7 mg / dL, Na: 134 mEq / L\n\u00a06 mEq / L, Cl: 80 mEq / L, Acetone: 3+. Then the following statements is true?A)Patients with normal blood pH without metabolic acid-base disorders\nB)Patients with metabolic acidosis with metabolic alkalosis\nC)Patients with metabolic acidosis with respiratory alkalosis\nD)Patients with metabolic alkalosis with respiratory acidosis", "subject_name": null, "output0": "The patient's blood pH is normal (7.40), and there is no evidence of metabolic acid-base disorders (e.g., elevated HCO3- or BUN/Cr ratio). Therefore, option A is the correct answer.\n\n", "output1": "The patient's blood biochemistry results show that they have metabolic acidosis with an elevated HCO3- level (24 mEq/L) and a normal pH (7.40). This indicates that the patient has a mixed acid-base disorder, with both metabolic acidosis and metabolic alkalosis. Therefore, the correct answer is B)Patients with metabolic acidosis with metabolic alkalosis.\n\n", "output2": "The patient's arterial blood pH of 7.40 and the blood biochemical examination results of HCO3-: 24 mEq/L and Acetone: 3+ indicate that the patient has metabolic acidosis with respiratory alkalosis.\n\n", "output3": "The patient's arterial blood pH is 7.40, which is slightly alkalotic. The blood biochemical examination shows that the patient has a high anion gap metabolic acidosis, with elevated levels of HCO3- and Cl-. This indicates that the patient has a mixed acid-base disorder, with both metabolic alkalosis and respiratory acidosis. Therefore, the correct answer is D)Patients with metabolic alkalosis with respiratory acidosis.\n\n"}, {"question": "Thrombocythemia is characterized by", "correct_answer": "Platelets elevation", "correct_idx": 0, "options": ["A)Platelets elevation", "B)Low platelets", "C)Neutrophilia", "D)Monocytosis"], "prompt": "Thrombocythemia is characterized byA)Platelets elevation\nB)Low platelets\nC)Neutrophilia\nD)Monocytosis", "subject_name": "Medicine", "output0": "Thrombocythemia is a disorder characterized by an increase in platelet count. Therefore, the correct answer is A) Platelets elevation.\n\n", "output1": "Thrombocythemia is characterized by low platelet counts.\n\n", "output2": "Thrombocythemia is characterized by an increase in the number of platelets in the blood. This is the opposite of thrombocytopenia, which is a decrease in the number of platelets.\n\n", "output3": "Thrombocythemia is a condition characterized by an elevated number of platelets in the blood. It is not associated with neutrophilia (high white blood cell count), low platelets, or monocytosis (high monocyte count).\n\n"}, {"question": "In eukaryotes, the RNA polymerase that transcribes the transference RNA genes is:", "correct_answer": "III.", "correct_idx": 2, "options": ["A)I.", "B)II.", "C)III.", "D)IV."], "prompt": "In eukaryotes, the RNA polymerase that transcribes the transference RNA genes is:A)I.\nB)II.\nC)III.\nD)IV.", "subject_name": "biology", "output0": "The RNA polymerase that transcribes the transfer RNA genes in eukaryotes is type I RNA polymerase.\n\n", "output1": "The RNA polymerase that transcribes the transfer RNA genes in eukaryotes is II, which is the main form of RNA polymerase found in eukaryotic cells.\n\n", "output2": "RNA polymerase III is the enzyme responsible for transcribing the transfer RNA genes in eukaryotic cells. Therefore, option C is the correct answer.\n\n", "output3": "The correct answer is D)IV because the RNA polymerase that transcribes the transfer RNA genes in eukaryotes is RNA polymerase IV.\n\n"}, {"question": "A 78-year-old woman presents a 2-year history of episodic amnesia that has been associated in recent months with difficulty recognizing familiar faces, apraxia of dress, anomie, and temporary disorientation. The family confirms a clear functional deterioration in instrumental activities of daily life with respect to its previous level. The patient shows a very evident anosognosia. General analytical studies, thyroid hormones and vitamin B12 are normal. Which of the following clinical findings did you NOT expect to find in this situation?", "correct_answer": "REM sleep behavior disorder.", "correct_idx": 1, "options": ["A)Neuritic plaques and neurofibrillary tangles in the hippocampus, temporal cortex and Meynert's nucleus as findings of pathological anatomy.", "B)REM sleep behavior disorder.", "C)Medial temporal cortical atrophy in cerebral magnetic resonance.", "D)ApoE 3/4 heterozygous genotype."], "prompt": "A 78-year-old woman presents a 2-year history of episodic amnesia that has been associated in recent months with difficulty recognizing familiar faces, apraxia of dress, anomie, and temporary disorientation. The family confirms a clear functional deterioration in instrumental activities of daily life with respect to its previous level. The patient shows a very evident anosognosia. General analytical studies, thyroid hormones and vitamin B12 are normal. Which of the following clinical findings did you NOT expect to find in this situation?A)Neuritic plaques and neurofibrillary tangles in the hippocampus, temporal cortex and Meynert's nucleus as findings of pathological anatomy.\nB)REM sleep behavior disorder.\nC)Medial temporal cortical atrophy in cerebral magnetic resonance.\nD)ApoE 3/4 heterozygous genotype.", "subject_name": "medicine", "output0": "The presence of neuritic plaques and neurofibrillary tangles in the hippocampus, temporal cortex, and Meynert's nucleus is not expected in a 78-year-old woman with a history of episodic amnesia, apraxia of dress, anomie, and temporary disorientation. These findings are more typical of Alzheimer's disease, which is a degenerative disorder that affects cognitive function and is not typically seen in this age group.\n\n", "output1": "REM sleep behavior disorder is not a typical finding in the clinical presentation of this patient. The patient's symptoms of episodic amnesia, apraxia of dress, anomie, and temporary disorientation are more consistent with a neurodegenerative disorder such as Alzheimer's disease, which is characterized by the presence of neuritic plaques and neurofibrillary tangles in the hippocampus, temporal cortex, and Meynert's nucleus.\n\n", "output2": "The patient's symptoms of episodic amnesia, apraxia of dress, anomie, and temporary disorientation are consistent with a diagnosis of Alzheimer's disease. However, medial temporal cortical atrophy in cerebral magnetic resonance is not a common finding in Alzheimer's disease. Therefore, it is not expected to find this finding in this situation.\n\n", "output3": "The presence of ApoE 3/4 heterozygous genotype is not a typical finding in Alzheimer's disease.\n\n"}, {"question": "IL- 1 activated by-", "correct_answer": "Capsase 1", "correct_idx": 0, "options": ["A)Capsase 1", "B)Capsase 3", "C)Capsase 8", "D)Capsase 5"], "prompt": "IL- 1 activated by-A)Capsase 1\nB)Capsase 3\nC)Capsase 8\nD)Capsase 5", "subject_name": "Pathology", "output0": "Capsase 1 is the enzyme that is most strongly activated by IL-1. It is responsible for the degradation of extracellular matrix components, which is an important aspect of the inflammatory response.\n\n", "output1": "Capsase 3 is a key enzyme involved in the inflammasome pathway, which is activated by the presence of pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs). The inflammasome is a complex that plays a crucial role in the innate immune response to infection and inflammation.\n\n", "output2": "Capsase 8 is the most abundant caspase in the brain and is primarily involved in the regulation of inflammation. The activation of Capsase 8 leads to the release of pro-inflammatory cytokines, which in turn can activate other caspases, such as Caspase 3, and lead to neurodegeneration.\n\n", "output3": "Capsase 5 is the primary activator of the inflammatory response in the body. It is a pro-inflammatory caspase that plays a key role in the regulation of inflammation and the immune response.\n\n"}, {"question": "Parathormone stimulates the:", "correct_answer": "Bone resorption by osteoclasts.", "correct_idx": 2, "options": ["A)Osteoprotegerin secretion by osteoblasts.", "B)Renal phosphate reabsorption.", "C)Bone resorption by osteoclasts.", "D)Formation of 24,25 dihydroxycholecalciferol."], "prompt": "Parathormone stimulates the:A)Osteoprotegerin secretion by osteoblasts.\nB)Renal phosphate reabsorption.\nC)Bone resorption by osteoclasts.\nD)Formation of 24,25 dihydroxycholecalciferol.", "subject_name": "biology", "output0": "Parathyroid hormone (PTH) stimulates the secretion of osteoprotegerin by osteoblasts. Osteoprotegerin is a protein that inhibits the activity of osteoclasts, which are the cells responsible for bone resorption. By inhibiting osteoclast activity, PTH promotes bone formation and prevents bone loss.\n\n", "output1": "Parathyroid hormone (PTH) stimulates the reabsorption of phosphate by the kidneys, which helps regulate calcium levels in the blood.\n\n", "output2": "Parathyroid hormone (PTH) stimulates the activity of osteoclasts, which are responsible for bone resorption. This leads to an increase in the release of calcium and phosphate into the bloodstream.\n\n", "output3": "Parathyroid hormone (PTH) stimulates the formation of 24,25 dihydroxycholecalciferol, a vitamin D metabolite that plays a crucial role in bone metabolism. This process is mediated by the enzyme CYP24A1, which is induced by PTH.\n\n"}, {"question": "A 19-year-old woman is brought to the emergency department by ambulance after experiencing a first-time seizure. She as preparing for an exam at her college\u2019s library, in her normal state of health and collapsed. When she regained consciousness she was surrounded by students and staff. The emergency personnel assessed her condition and brought her in. Past medical history is significant for major depressive disorder. Her primary care physician prescribed a medication for her depression, but she has not taken it for several days because she was concerned about weight gain. Family medical history is insignificant for neurological disorders. Instead, for the past 10 days, she has been taking her roommate\u2019s antidepressant medication instead. Today her blood pressure is 100/80 mm Hg, pulse 102/min, respirations 12/min and he BMI is 15 kg/m2. Physical examination reveals pale and dry mucosa and conjunctiva, and lanugo on her arms and legs. What medication is the patient most likely taking?", "correct_answer": "Bupropion", "correct_idx": 0, "options": ["A)Bupropion", "B)Gabapentin", "C)Selegiline", "D)Amitriptyline"], "prompt": "A 19-year-old woman is brought to the emergency department by ambulance after experiencing a first-time seizure. She as preparing for an exam at her college\u2019s library, in her normal state of health and collapsed. When she regained consciousness she was surrounded by students and staff. The emergency personnel assessed her condition and brought her in. Past medical history is significant for major depressive disorder. Her primary care physician prescribed a medication for her depression, but she has not taken it for several days because she was concerned about weight gain. Family medical history is insignificant for neurological disorders. Instead, for the past 10 days, she has been taking her roommate\u2019s antidepressant medication instead. Today her blood pressure is 100/80 mm Hg, pulse 102/min, respirations 12/min and he BMI is 15 kg/m2. Physical examination reveals pale and dry mucosa and conjunctiva, and lanugo on her arms and legs. What medication is the patient most likely taking?A)Bupropion\nB)Gabapentin\nC)Selegiline\nD)Amitriptyline", "subject_name": null, "output0": "The patient's symptoms of a first-time seizure, recent use of an antidepressant medication, and history of depression suggest that she is most likely taking bupropion. Bupropion is a commonly prescribed antidepressant medication that can cause seizures in some individuals, particularly when it is taken in combination with other medications or when the patient has a history of seizure disorders. The patient's pale and dry mucosa and conjunctiva, and lanugo on her arms and legs are also consistent with bupropion use.\n\n", "output1": "The patient's symptoms of pale and dry mucosa and conjunctiva, and lanugo on her arms and legs, along with her history of taking her roommate's antidepressant medication, suggest that she is taking an anticonvulsant medication such as gabapentin. Additionally, the patient's history of depression and recent seizure activity also suggest that she may be taking an antidepressant medication. Gabapentin is a medication that is commonly used to treat seizures and other neurological conditions, and it can cause weight gain as a side effect.\n\n", "output2": "The patient is most likely taking Selegiline, as it is a medication commonly used to treat depression and is known to cause dry mouth, pale skin, and lanugo (excessive hair growth) as side effects. Additionally, the patient's history of taking her roommate's antidepressant medication instead of her own prescribed medication suggests that she may be taking a medication that is not prescribed for her.\n\n", "output3": "The patient is most likely taking Amitriptyline because she has been taking her roommate's antidepressant medication for the past 10 days, and Amitriptyline is a commonly prescribed medication for depression. Additionally, the patient's symptoms of pale and dry mucosa and conjunctiva, and lanugo on her arms and legs are consistent with the side effects of Amitriptyline.\n\n"}, {"question": "Which of the following is not a Lewy body dementia (dementia with Lewy bodies, DLB) are the main symptoms?", "correct_answer": "Chorea", "correct_idx": 2, "options": ["A)Good times and bad cognitive functions", "B)Visual hallucinations", "C)Chorea", "D)Parkinson's Symptoms"], "prompt": "Which of the following is not a Lewy body dementia (dementia with Lewy bodies, DLB) are the main symptoms?A)Good times and bad cognitive functions\nB)Visual hallucinations\nC)Chorea\nD)Parkinson's Symptoms", "subject_name": null, "output0": "Good times and bad cognitive functions are not a main symptom of Lewy body dementia. Dementia with Lewy bodies is characterized by a fluctuating course, with periods of cognitive decline and relative stability. The main symptoms of DLB are visual hallucinations, chorea, and parkinsonism.\n\n", "output1": "Visual hallucinations are not a symptom of Lewy body dementia. The main symptoms of dementia with Lewy bodies (DLB) are cognitive impairment, fluctuations in cognitive function, visual hallucinations, and parkinsonism.\n\n", "output2": "Chorea is not a symptom of Lewy body dementia. Chorea is a movement disorder that is characterized by involuntary movements, such as jerky movements or tremors. While people with Lewy body dementia may experience some movement problems, chorea is not typically a symptom of this condition.\n\n", "output3": "Parkinson's symptoms are not a main symptom of Lewy body dementia. Dementia with Lewy bodies is characterized by cognitive decline, visual hallucinations, and fluctuations in cognitive function, but not by Parkinson's symptoms.\n\n"}]